1. END OF TREATMENT PET‐CT PREDICTS PROGRESSION‐FREE SURVIVAL IN DLBCL AFTER FIRST‐LINE TREATMENT: RESULTS FROM THE PHASE III GOYA STUDY. (June 2017) Authors: Kostakoglu, L.; Martelli, M.; Belada, D.; Carella, A.M.; Chua, N.; Gonzalez‐Barca, E.; Hong, X.; Pinto, A.; Sehn, L.H.; Shi, Y.; Tatsumi, Y.; Fingerle‐Rowson, G.; Mattiello, F.; Nielsen, T.; Sahin, D.; Vitolo, U.; Trněný, M. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 184 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PROGNOSTIC VALUE OF PET‐CT AFTER FIRST‐LINE IMMUNOCHEMOTHERAPY FOR FOLLICULAR LYMPHOMA IN THE PHASE III GALLIUM STUDY. (June 2017) Authors: Trotman, J.; Barrington, S.; Belada, D.; Meignan, M.; MacEwan, R.; Owen, C.; Ptáčník, V.; Rosta, A.; Fingerle‐Rowson, G.; Mattiello, F.; Nielsen, T.; Sahin, D.; Hiddemann, W.; Marcus, R.; Davies, A. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗